HFECX
Price
$55.20
Change
-$0.24 (-0.43%)
Updated
Nov 19 closing price
Net Assets
718.32M
VEURX
Price
$42.34
Change
-$0.22 (-0.52%)
Updated
Nov 19 closing price
Net Assets
35.25B
Interact to see
Advertisement

HFECX vs VEURX

Header iconHFECX vs VEURX Comparison
Open Charts HFECX vs VEURXBanner chart's image
Janus Henderson European Focus C
Price$55.20
Change-$0.24 (-0.43%)
VolumeN/A
Net Assets718.32M
Vanguard European Stock Investor
Price$42.34
Change-$0.22 (-0.52%)
VolumeN/A
Net Assets35.25B
HFECX vs VEURX Comparison Chart in %
View a ticker or compare two or three
VS
HFECX vs. VEURX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFECX is a Hold and VEURX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 35.3B vs. HFECX (718M). VEURX pays higher dividends than HFECX: VEURX (2.75) vs HFECX (0.36). HFECX was incepted earlier than VEURX: HFECX (24 years) vs VEURX (35 years). HFECX (2.25) is less costly to investors than VEURX (0.24). HFECX is a more actively managed with annual turnover of: 168.00 vs. VEURX (3.00). VEURX has a lower initial minimum investment than HFECX: VEURX (0) vs HFECX (2500). HFECX annual gain was more profitable for investors over the last year : 29.16 vs. VEURX (22.53). HFECX return over 5 years is better than : 62.28 vs. VEURX (38.88).
HFECXVEURXHFECX / VEURX
Total Expense Ratio2.060.24858%
Annual Report Gross Expense Ratio2.250.24938%
Fund Existence24 years35 years-
Gain YTD30.09724.812121%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets718M35.3B2%
Annual Yield % from dividends0.362.7513%
Returns for 1 year29.1622.53129%
Returns for 3 years58.7944.74131%
Returns for 5 years62.2838.88160%
Returns for 10 years83.1559.03141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUVL107.062.82
+2.71%
Nuvalent
SBC3.17N/A
N/A
SBC Medical Group Holdings Incorporated
TACOU10.35-0.01
-0.10%
Berto Acquisition Corp
HROW39.61-0.12
-0.30%
Harrow
GNTA1.79-0.20
-10.05%
Genenta Science SpA